Rosen Law Firm Urges Phreesia Shareholders to Review Legal Options Ahead of Important Court Deadline

NEW YORK – Rosen Law Firm, an internationally recognized investor rights law firm, has issued a reminder to investors of Phreesia, Inc. (NYSE: PHR) regarding an important upcoming deadline in an ongoing securities class action lawsuit. The firm is encouraging eligible shareholders to seek legal counsel and review their rights before the court-imposed deadline of July 13, 2026.

Investors Who Purchased Shares During the Class Period May Be Eligible

According to Rosen Law Firm, the securities class action concerns investors who purchased or otherwise acquired common stock of Phreesia, Inc. between May 8, 2025, and March 30, 2026. This timeframe is referred to as the “Class Period” in the litigation. Investors who acquired shares during this period may be entitled to seek compensation for alleged losses if the claims in the lawsuit are proven.

The law firm noted that affected investors may participate in the action through a contingency fee arrangement, meaning they would not be required to pay out-of-pocket legal fees or expenses in order to pursue a claim.

Lead Plaintiff Deadline Set for July 13, 2026

A critical aspect of the case is the upcoming July 13, 2026 deadline for investors seeking appointment as lead plaintiff. The lead plaintiff serves as the representative of the proposed class and helps oversee the litigation on behalf of all affected shareholders.

While investors may choose to seek lead plaintiff status, participation in any potential future recovery is not necessarily dependent upon serving in that role. Shareholders who do not wish to become lead plaintiff may still remain members of the proposed class if the case proceeds and a class is certified by the court.

Background of the Allegations

The lawsuit alleges that Phreesia and certain company representatives made statements during the Class Period that were materially false or misleading, or failed to disclose important information concerning the company’s business operations and financial outlook.

Specifically, plaintiffs claim that the company allegedly concealed information related to slowing customer demand and reduced visibility in important revenue-generating business segments. The complaint further alleges that pharmaceutical marketing commitments within Phreesia’s Network Solutions division were weaker than investors had been led to believe.

According to the allegations, these factors negatively affected the company's growth prospects and financial performance. When additional information regarding the company’s business conditions became known to the market, investors allegedly suffered financial losses.

Market Reaction Following Revenue Outlook Revision

The legal action follows events that occurred in late March 2026. On March 30, 2026, Phreesia announced its fourth-quarter fiscal 2026 financial results and disclosed that it was lowering its revenue outlook for fiscal year 2027. The announcement drew significant attention from investors and analysts monitoring the healthcare technology company.

Following the disclosure, Phreesia’s share price experienced a sharp decline. Market data cited in legal filings indicates that the company’s stock fell approximately 26.5% on March 31, 2026, prompting scrutiny from investors and leading to the filing of securities litigation.

About Phreesia

Phreesia is a healthcare technology company that provides an integrated software and payments platform designed to support healthcare organizations across the United States and Canada. The company's solutions are intended to improve patient intake, administrative workflows, and healthcare engagement through digital technology.

As a publicly traded company listed on the New York Stock Exchange under the ticker symbol PHR, Phreesia's financial performance and business outlook are closely followed by institutional and retail investors alike.

Rosen Law Firm Highlights Experience in Securities Litigation

In its investor notice, Rosen Law Firm emphasized its experience in securities class action and shareholder litigation. The firm stated that it has represented investors worldwide and has secured significant recoveries in securities-related cases over the years.

The firm also highlighted industry recognition received for its work in shareholder rights litigation, noting rankings and accolades from legal industry organizations. Rosen Law Firm has frequently appeared among leading firms handling securities class action settlements and investor recovery matters.

What Investors Should Know

Potential Class Members

Investors who purchased Phreesia common stock between May 8, 2025, and March 30, 2026, may fall within the proposed class definition and may wish to evaluate their legal options.

Lead Plaintiff Considerations

Shareholders interested in taking a more active role in the litigation may seek appointment as lead plaintiff. Such investors must submit the appropriate motion to the court no later than July 13, 2026.

No Upfront Legal Costs

The action is being pursued on a contingency fee basis, meaning legal fees are generally payable only if there is a successful recovery in the case.

Ongoing Legal Proceedings

The securities class action remains in its early stages, and the allegations contained in the complaint have not been proven in court. As with all litigation, defendants are expected to have the opportunity to respond to the claims and present their defenses through the judicial process. Investors and market participants will continue to monitor developments as the case moves forward.

Legal experts note that securities class actions often involve extensive review of company disclosures, financial statements, earnings guidance, and communications with investors. The outcome of such cases can depend on a wide range of legal and factual considerations evaluated by the court.

Conclusion

With the July 13, 2026 lead plaintiff deadline approaching, investors who purchased Phreesia shares during the relevant period are being encouraged to review the details of the lawsuit and understand their legal rights. The case centers on allegations concerning the company's business outlook, revenue visibility, and disclosures to investors. As proceedings continue, affected shareholders may consider consulting experienced securities litigation counsel to determine the most appropriate course of action.

#Phreesia #SecuritiesClassAction #InvestorRights #RosenLawFirm #SlimScan #GrowthStocks #CANSLIM